Pharmaxis chief executive Alan Robertson says he might find time to give himself a small pat on the back on Wednesday when the company’s flagship drug will finally get reimbursed by the Australian government.

Pharmaceutical companies spend their time concentrating on patients but pitching to governments which are generally the only payers of consequence.